Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724498 | SCV000230363 | pathogenic | not provided | 2014-12-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724498 | SCV001167886 | pathogenic | not provided | 2024-10-14 | criteria provided, single submitter | clinical testing | Observed in the homozygous state or in the presence of another SLC45A2 variant in individuals with oculocutaneous albinism in the literature (PMID: 28170084, 14722913); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21677667, 14722913, 28976636, Moreno-Artero2022[paper], 28298193, 24096233, 36553465, 28170084) |
Genetic Services Laboratory, |
RCV000724498 | SCV002072141 | pathogenic | not provided | 2017-07-20 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004566683 | SCV005056865 | pathogenic | SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR | 2024-03-10 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000004758 | SCV000024934 | pathogenic | Oculocutaneous albinism type 4 | 2004-02-01 | no assertion criteria provided | literature only |